Skip to main content
. 2020 Oct 25:1–18. doi: 10.1080/07391102.2020.1837681

Table 1.

Interaction of the SARS-CoV-2 main protease with phyto-compounds and FDA anti-viral drugs.

Compounds name Source PubChem CID ABB Docking score (kcal/mol) Key residue interaction
Momordicine M. charantia L. 14807332 MDC –6.6a H-bond: Asn 142; Glu 166
Deacetylnimninene A. indica 102004582 DCN –6.1a H-bond: Cys 44; Glu 166
Margolonone M. charantia L. 189726  MGN 5.5 H-bond: His 163, Glu 166, Ser 144, Gly 143
Momordiciode F2 M. charantia L. 44445567 MDF 5.2 H-bond: Pro 168, Glu 166
Nimbandiol A. indica 157277 NBD 4.8 H-bond: Glu 166, Asn 142, Gln 198, Pi-pi: His 41
17-Hydroxyazadiradione A. indica 52951892  HXD −4.0 H-bond: Glu 166
Ribavirin   37542 RBV –6.2a H-bond: His 163; Phe 140
Remdesivir   121304016 RMS –8.4a H-bond: Glu 166; Cys 145; Thr 190
Hydroxychloroquine   178396 HCQ 3.4 H-bond: Asn 142; Cys 44
Pi-cation: His 44
Alpha-ketoamide   10129151 AK 8.5 H-bond: Cys 44, Hie 41, Asn 142, His 163, Glu 166
X77   145998279 X77 9.6 H-bond: Cys 44, Hie 41, Asn 142, Hie 163, Glu 166, Gly 143

ABB, abbreviations.

a

The lowest binding energy for respective ligand with the target protein.